๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Carcinogenic and co-carcinogenic potential of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a host-mediated in vivo/in vitro assay

โœ Scribed by Th. Massa; A. Esmaelli; B. Schlatterer; H. Hagenmaier; P. Chandra


Book ID
116078666
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
692 KB
Volume
23
Category
Article
ISSN
0045-6535

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Carcinogenicity of 2,3,7,8-tetrachlorodi
โœ Stefanie Knerr; Dieter Schrenk ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 230 KB

## Abstract The contaminant 2,3,7,8โ€tetrachlorodibenzoโ€__p__โ€dioxin (TCDD) is a prototype compound of a whole class of halogenated aromatic hydrocarbons termed โ€˜dioxinlikeโ€™ contaminants present in food, human tissue, mothers milk, and environmental samples. Among the various adverse effects caused

Effects of 2,3,7,8-tetrachlorodibenzo-p-
โœ Ulf G. Ahlborg; Tuula Thunberg ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 385 KB

The metabolism of pentachlorophenol has been studied in the rat after pretreatments with phenobarbital, 3-methyl cholanthrene or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In addition to the previously identified metabolite, tetrachloro-p-hydroquinone, trichloro-p-hydroquinone has been identified i

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCD
โœ Muralidhara, ;Matsumura, Fumio ;Blankenship, Alan ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 978 KB

## Abstract 2,3,7,8โ€Tetrachlorodibenzoโ€__p__โ€dioxin (TCDD) is a potent immunosuppressant in several animal species. The purpose of this study was to determine if TCDD affected the activity of adenosine deaminase (ADA), a purine metabolizing enzyme that is vital to the proper functioning of the immu

Comparison of chronic toxicity and carci
โœ Nigel J. Walker; Michael E. Wyde; Lawrence J. Fischer; Abraham Nyska; John R. Bu ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 544 KB

## Abstract The cancer bioassay for 2,3,7,8โ€tetrachlorodibenzoโ€__p__โ€dioxin (TCDD) conducted by the Dow Chemical company in the mid 70s has been used extensively for conducting quantitative cancer risk assessments for human exposure to TCDD. More recently the National Toxicology Program (NTP) condu